This report aims to provide insight into the overal clinical trial landscape for rescue clinical trials, which we have defined as trials with delayed estimated start date and delayed estimated end date.
The purpose of this report is to provide insight into the overall clinical trial landscape for rescue clinical trials, trials with delayed estimated start date and delayed estimated end date.
The purpose of this report is to provide insight into the overall clinical trial landscape for rescue clinical trials, trials with delayed estimated start date and delayed estimated end date.
Scope
- The clinical trials data used for these analyses were extracted from the publisher’s Clinical Trials Database. The data included clinical trials since 2010, which were captured in the database as of October 28, 2021.
- The trials were analyzed and segmented by all rescue clinical trials, trials with delayed estimated start date, and trials with delayed estimated end date. Further analysis was conducted based on phase, status, multinational vs. single country, sponsor type, top industry and non-industry sponsors, trials utilizing CROs, virtual components, therapy area, and drugs. In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.
Reasons to Buy
- Understand the rescue trials landscape
- The trends of rescue clinical trials with delayed estimated start date
- The trends of rescue clinical trials with delayed estimated end date
Table of Contents
- Executive Summary
- Introduction
- Rescue Clinical Trials
- Rescue Clinical Trials: Delayed Estimated Start Date
- Rescue Clinical Trials: Delayed Estimated End Date
- Key Findings
- Appendix
List of Figures
Figure 1: Number of Rescue Clinical Trials, by Year
Figure 2: Number of Rescue Clinical Trials, by Single-Country vs. Multinational
Figure 3: Top Reasons for Terminated Trials, by Phase
Figures 4 & 5: Completion Rate of Rescue Clinical Trials, by Use of Virtual Trial Components & CRO
Figure 6: Percent of Rescue Clinical Trials to Overall Clinical Trials Since 2010
Figure 7: Top Drugs Used in Rescue Clinical Trials, by Status
Figure 8: Number of Rescue Clinical Trials by Delayed Estimated Start Date, by Year
Figures 9 & 10: Number of Rescue Clinical Trials by Delayed Estimated Start Date, by Phase & Status
Figure 11: Number of Single-Country Rescue Clinical Trials by Delayed Estimated Start Date, by Region and Phase
Figure 12: Number of Multinational Rescue Clinical Trials by Delayed Estimated Start Date, by Region and Phase
Figure 13: Number of Rescue Clinical Trials by Delayed Estimated Start Date, by Sponsor Type
Figure 14: Top Industry Sponsors for Rescue Clinical Trials by Delayed Estimated Start Date, by Status
Figure 15: Top Non-Industry Sponsors for Rescue Clinical Trials by Delayed Estimated Start Date, by Status
Figure 16: Percent of Rescue Clinical Trials by Delayed Estimated Start Date, by Utilization of CRO & Status
Figure 17: Number of Clinical Trials by Delayed Estimated Start Date, by CRO & Status
Figure 18: Number of Rescue Clinical Trials by Delayed Estimated End Date, by Year
Figures 19 & 20: Number of Rescue Clinical Trials by Delayed Estimated End Date, by Phase & Status
Figure 21: Number of Single-Country Rescue Clinical Trials by Delayed Estimated End Date, by Phase
Figure 22: Number of Multinational Country Rescue Clinical Trials by Delayed Estimated End Date, by Phase
Figure 23: Number of Rescue Clinical Trials by Delayed Estimated End Date, by Sponsor Type
Figure 24: Top Industry Sponsors for Rescue Clinical Trials by Delayed Estimated End Date, by Status
Figure 25: Top Non-Industry Sponsors for Rescue Clinical Trials by Estimated Delayed End Date, by Status
Figure 26: Percent of Rescue Clinical Trials by Estimated Delayed End Date, by Utilization of CRO & Status
Figure 27: Number of Clinical Trials by Delayed Estimated End Date, by CRO & Status
